Income Statement (IVERIC/BIO)

Technical Analysis Historical Data Financials News & Analysis

IVERIC/BIO NEWS

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update By Site Author - 1 month ago

- Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partners New Drug Application for ARCATUS®(XIPERE®) for Uveitic Macular Edem… [+16915 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		183.01 0.71
0.39%
CVX 		138.76 -1.34
-0.96%
CAT 		305.97 -1.09
-0.36%
INTC 		20.59 0.08
0.37%
MSFT 		394.08 2.92
0.75%
DIS 		90.73 0.57
0.63%
DOW 		30.04 0.09
0.3%
CSCO 		56.99 0.15
0.26%
GS 		546.16 -0.24
-0.04%